Health care stocks were edging higher premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was advancing by 0.2% and the iShares Biotechnology ETF (IBB) was recently up 0.3%.
Amneal Pharmaceuticals (AMRX) shares were up more than 3% after the company said it expects to report Q2 income before taxes of $45 million to $56 million, compared with $20 million a year earlier.
Evotec (EVO) shares were down nearly 13% after the company lowered its fiscal 2025 revenue guidance to reflect a shift in the revenue mix.
Sarepta Therapeutics (SRPT) shares were nearly 10% lower after the company said in a regulatory filing the US Food and Drug Administration has placed a clinical hold on its gene therapy trials for limb-girdle muscular dystrophy.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。